CRL
Charles River Laboratories International Inc.

916
Loading...
Loading...
News
all
press releases
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the creation of a global, cross-functional Scientific Advisory Board, led by Dr. Namandj N. Bumpus, to guide the Companys...
Business Wire·3d ago
News Placeholder
More News
News Placeholder
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2025 financial results on Wednesday, November 5th, before the market opens. A conference call has been scheduled...
Business Wire·4d ago
News Placeholder
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Zacks·8d ago
News Placeholder
Pediatrix Medical Group, Inc. (MD) Soars to 52-Week High, Time to Cash Out?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·12d ago
News Placeholder
CRL Stock Rises Following New Strategic Oncology Collaborations
Charles River shares rise after new collaborations with PICI and CHLA, boosting its oncology and cell therapy pipeline momentum.
Zacks·1mo ago
News Placeholder
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
Charles River's DSA growth, acquisitions and collaborations support momentum, but forex and macro headwinds weigh on its outlook.
Zacks·1mo ago
News Placeholder
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Zacks·2mo ago
News Placeholder
Charles River Stock May Benefit From Joining EASYGEN Consortium
CRL joins EASYGEN to speed CAR-T therapy delivery, which may boost patient access and investor sentiment.
Zacks·2mo ago
News Placeholder
Interpreting Charles River (CRL) International Revenue Trends
Review Charles River's (CRL) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Zacks·2mo ago
News Placeholder
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Charles River (CRL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·2mo ago

Latest CRL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.